Protean » O nás
Poslední aktualizace proběhla 27.5. 2011
O nás
Společnost Protean s.r.o. byla založena v roce 2008 za účelem výzkumu, vývoje a výroby moderních diagnostických prostředků na základě analýzy DNA a genového inženýrství.
Název společnosti pochází z řecké mytologie. Proteus byl původním bohem moře, který znal budoucnost a mohl nabývat různých forem života. Odsud plyne přídavné jméno "Protean", jehož význam je "měnlivý", "universální", nebo "adaptabilní".
Naši zaměstnanci R&D
Vedoucí výzkumu a vývoje
Profesní kariera:
| Laboratory of Immunology, Research Institute of Endocrinology, Prague, Czech Republic |
1989-1991 |
| Institute of Biochemistry and Medical chemistry, University of Bari, Bari, Italy |
1993 |
| Institute of Physiology, ASCR, Prague, Czech Republic |
1991-1997 |
| Johns Hopkins University, Oncology Center, Baltimore, Maryland, USA, postdoctoral stay |
1997-2000 |
| Department of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital of Ulm, Ulm, Germany, postdoctoral stay, habilitation |
2000-2005 |
| GEN-TREND s.r.o., Czech Republic, Research & Development Director |
2005-2008 |
| Protean s.r.o., Czech Republic, Research & Development Director, Ceo |
2008-present |
Grant projects:
| Grant Agency of the Czech Republic: Regulation of expression and function of pyrogenic cytokines in somatic cells. |
1995-1997 |
| National Institute of Health, USA: Cloning and characterization of novel Kaposi’s sarcoma herpes virus-encoded interferon regulatory factors. |
1997-2000 |
| University of Ulm, Germany: Cloning and characterization of human homologue of viral interferon regulatory factor 2 (vIRF-2). |
2001-2003 |
| Deutsches Forschunggesellschaft (DFG), Germany: Characterization of virus-induced transcription factors and regulation of gene expression of the host cell. |
2002-2004 |
| Ministry of Industry and Trade of the Czech Republic, Project Impulse: Development and manufacture of new generation of molecular biological diagnostic kits for parallel "macroarray" detection of human pathogens. |
2004-2006 |
| German-Israeli Project Cooperation (DIP), The German Ministry for Education and Research (BMBF), Germany: The role of intracellular IL-1 alpha in health and disease: mechanisms of action and therapeutic applications. |
2005 |
For a publication list please click here.
Vedoucí laboratoře
Profesní kariera:
| SÚKL, Czech Republic |
1990-1997 |
| Johns Hopkins University, Cardiology Center, Baltimore, Maryland, USA, research assistant |
1997-2000 |
| Department of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital of Ulm, Ulm, Germany, PhD student |
2001-2004 |
| Department of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital of Ulm, Ulm, Germany, Postdoctoral fellow |
2004-2005 |
| GEN-TREND s.r.o., Czech Republic, Laboratory Head |
2005-2008 |
| Protean s.r.o., Czech Republic, Laboratory Head |
2008-present |
Publication list:
| Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure. Akar FG, Wu RC, Juang GJ, Tian Y, Burysek M, Disilvestre D, Xiong W, Armoundas AA, Tomaselli GF, Am J Physiol Heart Circ Physiol. 288(6):H2887-96. |
2005 |
| Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Rose J, Armoundas AA, Tian Y, DiSilvestre D, Burysek M, Halperin V, O'Rourke B, Kass DA, Marbán E, Tomaselli GF. Am J Physiol Heart Circ Physiol. 288(5):H2077-87. |
2005 |
| Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. Buryskova M, Pospisek M, Grothey A, Simmet T, Burysek L. J Biol Chem. 6;279(6):4017-26. Epub 2003 Nov 11. |
2004 |
Laborantka
Profesní kariera:
| Všeobecné gymnázium, Třeboň
|
2003-2007 |
| JCU v Českých Budějovicích, ZSF, Obor: Zdravotní laborant
|
2008-2011 |
| Protean s.r.o., Laborantka |
2011- |
